Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid.
Correale P, Messinese S, Marsili S, Ceciarini F, Pozzessere D, Petrioli R, Sabatino M, Cerretani D, Pellegrini M, Di Palma T, Neri A, Calvanese A, Pinto E, Giorgi G, Francini G. Correale P, et al. Among authors: pozzessere d. Br J Cancer. 2003 Jul 21;89(2):239-42. doi: 10.1038/sj.bjc.6601045. Br J Cancer. 2003. PMID: 12865908 Free PMC article. Clinical Trial.
Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a phase Ib clinical trial.
Correale P, Campoccia G, Tsang KY, Micheli L, Cusi MG, Sabatino M, Bruni G, Sestini S, Petrioli R, Pozzessere D, Marsili S, Fanetti G, Giorgi G, Francini G. Correale P, et al. Among authors: pozzessere d. Eur J Cancer. 2001 May;37(7):892-902. doi: 10.1016/s0959-8049(01)00063-6. Eur J Cancer. 2001. PMID: 11313178 Clinical Trial.
Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes.
Correale P, Cusi MG, Sabatino M, Micheli L, Pozzessere D, Nencini C, Valensin PE, Petrioli R, Giorgi G, Zurbriggen R, Gluck R, Francini G. Correale P, et al. Among authors: pozzessere d. Eur J Cancer. 2001 Nov;37(16):2097-103. doi: 10.1016/s0959-8049(01)00241-6. Eur J Cancer. 2001. PMID: 11597390
A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
Correale P, Micheli L, Vecchio MT, Sabatino M, Petrioli R, Pozzessere D, Marsili S, Giorgi G, Lozzi L, Neri P, Francini G. Correale P, et al. Among authors: pozzessere d. Br J Cancer. 2001 Nov 30;85(11):1722-30. doi: 10.1054/bjoc.2001.2136. Br J Cancer. 2001. PMID: 11742494 Free PMC article.
Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma.
Francini G, Petrioli R, Gonnelli S, Correale P, Pozzessere D, Marsili S, Montagnani A, Lucani B, Rossi S, Monaco R, Manganelli A, Salvestrini F, Fiaschi AI. Francini G, et al. Among authors: pozzessere d. Cancer. 2001 Sep 15;92(6):1468-74. doi: 10.1002/1097-0142(20010915)92:6<1468::aid-cncr1471>3.0.co;2-s. Cancer. 2001. PMID: 11745224
Weekly epirubicin in patients with hormone-resistant prostate cancer.
Petrioli R, Fiaschi AI, Pozzessere D, Messinese S, Sabatino M, Marsili S, Correale P, Manganelli A, Salvestrini F, Francini G. Petrioli R, et al. Among authors: pozzessere d. Br J Cancer. 2002 Sep 23;87(7):720-5. doi: 10.1038/sj.bjc.6600525. Br J Cancer. 2002. PMID: 12232753 Free PMC article. Clinical Trial.
High-affinity HLA-A(*)02.01 peptides from parathyroid hormone-related protein generate in vitro and in vivo antitumor CTL response without autoimmune side effects.
Francini G, Scardino A, Kosmatopoulos K, Lemonnier FA, Campoccia G, Sabatino M, Pozzessere D, Petrioli R, Lozzi L, Neri P, Fanetti G, Cusi MG, Correale P. Francini G, et al. Among authors: pozzessere d. J Immunol. 2002 Nov 1;169(9):4840-9. doi: 10.4049/jimmunol.169.9.4840. J Immunol. 2002. PMID: 12391194
27 results